PBYI
#2959
Puma Biotechnology Inc - Common Stock
9.0 6 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.95%
Monthly Change
+16.30%
6 month change
+64.43%
Year Change
+79.41%
Previous Close
9.2 4
Open
9.0 6
Low
9.0 6
High
9.0 6
Volume
59
Financials
- Market Capitalization 467.68 M
- Employee 179
- Founded 2007
- CEO N/A
- Website www.pumabiotechnology.com
- Headquarter Delaware, United States
- FIGI BBG0018YXYX7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.75
Price to sales ratio
1.32
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2944 |  PRTA Prothena Corporation plc - Ordinary Shares | 9.33 USD | +2.64% | -1.37% | +9.76% | +14.20% | 478.97 M USD | ||
| 2954 |  CCCC C4 Therapeutics, Inc. - Common Stock | 3.85 USD | -6.10% | -3.02% | +9.07% | +49.81% | 473.65 M USD | ||
| 2968 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.33 USD | -4.20% | -6.68% | -17.05% | +283.19% | 461.88 M USD | ||
| 2981 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.17 USD | -4.84% | -0.30% | +3.70% | -10.41% | 449.98 M USD |
Frequently asked questions about PUMA BIOTECHNOLOGY INC
What is the PUMA BIOTECHNOLOGY INC stock price today?
The current price of PUMA BIOTECHNOLOGY INC (PBYI) is 9.06. Over the past 24 hours, the stock has changed by -1.95%. Follow the PBYI chart for real-time price dynamics.
What is the stock ticker of PUMA BIOTECHNOLOGY INC?
PUMA BIOTECHNOLOGY INC trades under the ticker PBYI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PUMA BIOTECHNOLOGY INC stock going up?
PBYI has changed by -2.58% over the last week, +16.30% over the last month, and +79.41% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of PUMA BIOTECHNOLOGY INC?
PUMA BIOTECHNOLOGY INC currently has a market capitalization of 467.68 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were PUMA BIOTECHNOLOGY INC earnings last quarter?
Last quarter, PUMA BIOTECHNOLOGY INC reported earnings of 0.16 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was PUMA BIOTECHNOLOGY INC revenue for the last quarter?
PUMA BIOTECHNOLOGY INC reported quarterly revenue of 56.5 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was PUMA BIOTECHNOLOGY INC net income for the last quarter?
PUMA BIOTECHNOLOGY INC reported net income of 8.19 M for the last quarter. The previous quarter showed -3.75 M, which means net income changed by +318.20%.
How many employees does PUMA BIOTECHNOLOGY INC have?
As of the latest available data, PUMA BIOTECHNOLOGY INC has 179 employees. Workforce size can provide additional context about the company's scale and operations.
What is PUMA BIOTECHNOLOGY INC EBITDA?
PUMA BIOTECHNOLOGY INC EBITDA is 9.98 M, and its EBITDA margin is 17.67%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PUMA BIOTECHNOLOGY INC stock?
You can buy PUMA BIOTECHNOLOGY INC (PBYI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PUMA BIOTECHNOLOGY INC stock?
Investing in PUMA BIOTECHNOLOGY INC requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PBYI chart and related analysis on metatrader.com as part of your research.